Revolutionizing Drug Delivery: The Impact of Advanced Materials Science and Technology on Precision Medicine
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(3), P. 375 - 375
Published: March 15, 2025
Recent
progress
in
material
science
has
led
to
the
development
of
new
drug
delivery
systems
that
go
beyond
conventional
approaches
and
offer
greater
accuracy
convenience
application
therapeutic
agents.
This
review
discusses
evolutionary
role
nanocarriers,
hydrogels,
bioresponsive
polymers
enhanced
release,
target
accuracy,
bioavailability.
Oncology,
chronic
disease
management,
vaccine
are
some
applications
explored
this
paper
show
how
these
materials
improve
results,
counteract
multidrug
resistance,
allow
for
sustained
localized
treatments.
The
also
translational
barriers
bringing
advanced
into
clinical
setting,
which
include
issues
biocompatibility,
scalability,
regulatory
approval.
Methods
overcome
challenges
surface
modifications
reduce
immunogenicity,
scalable
production
methods
such
as
microfluidics,
harmonization
systems.
In
addition,
convergence
artificial
intelligence
(AI)
machine
learning
(ML)
is
opening
frontiers
personalized
medicine.
These
technologies
predictive
modeling
real-time
adjustments
optimize
needs
individual
patients.
use
can
be
applied
rare
underserved
diseases;
thus,
strategies
gene
therapy,
orphan
drugs
development,
global
distribution
may
hopes
millions
Language: Английский
Exploring the role of gut microbiota in antibiotic resistance and prevention
Devyani S. Dongre,
No information about this author
Ujjayni Saha,
No information about this author
Sunil D. Saroj
No information about this author
et al.
Annals of Medicine,
Journal Year:
2025,
Volume and Issue:
57(1)
Published: March 17, 2025
Background/Introduction
Antimicrobial
resistance
(AMR)
and
the
evolution
of
multiple
drug-resistant
(MDR)
bacteria
is
grave
public
health
concern.
To
combat
pandemic
AMR,
it
necessary
to
focus
on
novel
alternatives
for
drug
development.
Within
host,
interaction
pathogen
with
microbiome
plays
a
pivotal
role
in
determining
outcome
pathogenesis.
Therefore,
microbiome-pathogen
one
potential
targets
be
explored
antimicrobials.
Language: Английский